Can We Prevent Congenital Infection by Cytomegalovirus?
Cytomegalovirus
congenital infection
vaccines
Journal
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213
Informations de publication
Date de publication:
24 05 2023
24 05 2023
Historique:
received:
16
01
2023
medline:
26
5
2023
pubmed:
29
3
2023
entrez:
28
3
2023
Statut:
ppublish
Résumé
Cytomegalovirus is now the most common cause of congenital infections, leading to numerous abnormalities. After 50 years of failed attempts to develop a licensed vaccine to be given to women before pregnancy, modern platforms for vaccine construction allow hope for an effective prophylactic.
Identifiants
pubmed: 36975123
pii: 7091430
doi: 10.1093/cid/ciad179
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1705-1707Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Déclaration de conflit d'intérêts
Potential conflicts of interest. Consultancies to Moderna and Merck. S. A. P. also reports consulting fees from Sanofi, Janssen, Inovio, Valneva, GSK, and Adigenix; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Merck. S. A. P. is also a consultant to several companies developing vaccines against cytomegalovirus, including Merck, Moderna, GSK, Hookipa, VBI. All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.